Loading clinical trials...
Loading clinical trials...
A Phase III Randomized Controlled Open Label Comparative Multicentric Trial To Compare The Safety And Efficacy of Indigenous Recombinant Human Granulocyte Colony Stimulating Factor (rhG-CSF) With Neup...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shantha Biotechnics Limited
NCT06537726 · Leukemia, Leukemia, Myeloid, and more
NCT05245487 · Lymphoma, Chemotherapy-induced Neutropenia, and more
NCT04345900 · Chemotherapy-induced Neutropenia
NCT04134429 · Pediatric Cancer, Febrile Neutropenia, and more
NCT04460079 · Chemotherapy-induced Neutropenia
Indo American Cancer Institute and Research Centre
Hyderabad, Andhra Pradesh
Nizam's Institute of Medical Sciences
Hyderabad, Andhra Pradesh
Vedanta Institute of Medical Sciences
Ahmedabad, Gujarat
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions